← Leaderboards
Elizabeth M Petty
University Of Michigan At Ann Arbor
$2,442,815
Attributed
$2,442,815
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $305.8K · FY2005–10$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$2,442,815 · 1
By mechanism
R01$2,442,815 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Sally A. Camper$22,265,378
- Celina G Kleer$13,464,529
- Buffy Sue Ellsworth$1,687,124
- Kun-Liang Guan$23,941,835
- Andrzej A Dlugosz$18,965,035
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsCellular MorphologyAgarAnchorage-Independent GrowthAneuploidyAbnormal CellApoptosisAlpha TubulinAthymic MouseBreastBreast AdenocarcinomaBreast Cancer CellAnimalsAllelic ImbalanceCancer CellCarcinogenesisApoptoticCell CycleCell Cycle ProgressionCell Cycle RegulationCell DivisionCell NucleusCell ProliferationCharacteristics
Grant awards (9)
The role of SEPT9 in cell proliferation and oncogenesis$296,021
R01 · FY2010 · CA · contact PI
The role of SEPT9 in cell proliferation and oncogenesis$296,021
R01 · FY2009 · CA · contact PI
The role of SEPT9 in cell proliferation and oncogenesis$296,021
R01 · FY2008 · CA · contact PI
The role of SEPT9 in cell proliferation and oncogenesis$300,128
R01 · FY2007 · CA · contact PI
The role of SEPT9 in cell proliferation and oncogenesis$305,838
R01 · FY2006 · CA · contact PI
Characterization of a New 17q Breast/Ovarian Cancer Gene$44,997
R01 · FY2005 · CA
Characterization of a New 17q Breast/Ovarian Cancer Gene$306,129
R01 · FY2003 · CA
Characterization of a New 17q Breast/Ovarian Cancer Gene$301,049
R01 · FY2002 · CA
Characterization of a New 17q Breast/Ovarian Cancer Gene$296,611
R01 · FY2001 · CA